PJ

Pankaj Jha

Active Director Director DIN 11090621
DIN 11090621 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value •••• Premium profile

About Pankaj Jha

Data last updated:

Pankaj Jha is a Director at Evervital Lifesciences Private Limited (since 2025). The company operates in Pharma. Evervital Lifesciences Private Limited reported revenue of ₹48.18 Cr (FY 2025).

DIN 11090621
Primary Designation Director
Industry Pharma
First Appointment 08 May 2025
Oldest Company Age 4 yrs
Largest company Evervital Lifesciences Private Limited · ₹48.18 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 May 20252022₹48.18 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Evervital Lifesciences Private Limited
Premium access

Shareholding and investment profile for Pankaj Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankaj Jha

Pankaj Jha currently holds 1 directorship: Evervital Lifesciences Private Limited (Director, since 08 May 2025, revenue ₹48.18 Cr (FY 2025)).

Pankaj Jha was first appointed on 08 May 2025 as Director at Evervital Lifesciences Private Limited.

The current boards of Pankaj Jha's companies include Hemant Jain (Evervital Lifesciences Private Limited), Nitin Kumar Jain (Evervital Lifesciences Private Limited), Praful Rampratap Pande (Evervital Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available